本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CINGULATE INC.

5.55
+0.22004.13%
盤後5.50-0.0489-0.88%19:30 EDT
成交量:23.47萬
成交額:127.74萬
市值:8,070.70萬
市盈率:-1.56
高:5.55
開:5.35
低:5.18
收:5.33
52周最高:11.89
52周最低:3.16
股本:1,454.18萬
流通股本:1,411.18萬
量比:1.67
換手率:1.66%
股息:- -
股息率:- -
每股收益(TTM):-3.5600
每股收益(LYR):-4.4408
淨資產收益率:-198.74%
總資產收益率:-66.94%
市淨率:3.44
市盈率(LYR):-1.25

資料載入中...

公司資料

公司名字:
CINGULATE INC.
交易所:
NASDAQ
成立時間:
2012
員工人數:
14
公司地址:
1901 West 47th Place,Kansas City,Kansas,United States
郵編:
66205
電話:
傳真:
- -
簡介:
Cingulate Inc.於2012年12月14日在特拉華州成立。該公司是一家生物製藥公司,利用其專有的精準定時釋放藥物遞送平台,為注意缺陷多動障礙和焦慮症開發下一代產品。其主要候選藥物CTx-1301和CTx-1302旨在作為每日一次的多動症興奮劑藥物,同時也在開發CTx-2103,一種每日一次的丁螺環酮製劑,用於治療焦慮症。

董事

名稱
職位
John A. Roberts
Chairman of the Board and Independent Director
Bryan Lawrence
Independent Director
Jeffrey S. Ervin
Independent Director
Zhanpeng Jiang
Independent Director
Peter J. Werth
Director

股東

名稱
職位
Shane J. Schaffer
Chief Executive Officer and Director
Jennifer L. Callahan
Executive Vice President, Chief Financial Officer & Secretary
Bryan Downey
Executive Vice President and Chief Commercial Officer
Matthew N. Brams
Executive Vice President and Chief Medical Officer
Nilay D. Patel
Executive Vice President, Chief Legal Officer & Chief Compliance Officer
Raul R. Silva
Executive Vice President and Chief Science Officer